GTR 113410309
Bids Are Invited For Acquisition Of Medicine To Serve Initial Patient Of Court Demand.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
113410309
Tendering Authority
Subscribe to view
Tender No
111/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Medicine To Serve Initial Patient Of Court Demand.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
26-05-2026
Closed
Work Detail
Aripiprazole - Concentration: 1Mg/Ml; Suspension: Oral; Bottle: With At Least 100 Ml., Aripiprazole - Concentration: 20Mg/Ml; Suspension: Drops; Bottle: Containing At Least 30 Ml., Aripiprazole - Concentration: 30Mg; Pharmaceutical Form: Tablet, Betahistine (Hydrochloride) - Concentration: 24Mg; Pharmaceutical Form: Tablet, Cannabidiol - Concentration: 160, 32Mg/Ml; Solution: Oral; Bottle: 10Ml., Cannabidiol - Concentration: 79, 14Mg/Ml; Solution: Oral; Bottle: 30Ml., Cannabis Sativa L. (Extract) - Concentration: 200 Mg/Ml; Solution: Oral; Bottle: Minimum 10Ml., Clobazam - Concentration: 10Mg; Pharmaceutical Form: Tablet, Clonazepam - Concentration: 2Mg; Pharmaceutical Form: Tablet, Colchicine - Concentration: 0.5Mg; Pharmaceutical Form: Tablet, Cholecalciferol (Vitamin D3) - Concentration: 10,000Ui; Pharmaceutical Form: Capsule Or Tablet., Dapagliflozin - Concentration: 10Mg; Tablet: Coated., Dapagliflozin + Metformin - Concentration: 10 Mg + 1,000 Mg; Coated Tablet: Prolonged Release., Divalproex Sodium - Concentration: 500Mg; Tablet: Coated., Duloxetine (Hydrochloride) - Concentration: 60Mg; Capsule: Delayed Release., Empagliflozin - Concentration: 10Mg; Tablet: Coated., Empagliflozin + Linagliptin - Concentration: 25 Mg+5 Mg; Tablet: Coated., Enoxaparin - Concentration: 80Mg; Solution: Injectable; Filled Syringe: 0.8Ml., Eszopiclone - Concentration: 3Mg; Tablet: Coated., Etoricoxib 90Mg. Tablet, Ezetimibe + Rosuvastatin Calcium - Concentration: 10Mg + 40Mg; Pharmaceutical Form: Tablet, Ezetimibe + Rosuvastatin Calcium - Concentration: 10 Mg +10Mg; Capsule: Dura., Ezetimibe + Rosuvastatin Calcium - Concentration: 10 Mg +20Mg; Capsule: Dura., Ezetimibe - Concentration: 10Mg; Pharmaceutical Form: Tablet, Ginkgo Biloba (Extract) - Concentration: 80Mg; Tablet: Coated., Lisdexamfetamine (Dimesylate) - Concentration: 50Mg; Capsule: Dura., Methylphenidate (Hydrochloride) - Concentration: 10Mg; Pharmaceutical Form: Tablet, Olanzapine - Concentration: 10Mg; Tablet: Coated., Olanzapine - Concentration: 5Mg; Tablet: Coated., Olanzapine - Concentration: 2, Olmesartan (Medoxomila) + Hydrochlorothiazide - Concentration: 40Mg + 12.5 Mg; Tablet: Coated., Oxcarbazepine - Concentration: 600 Mg; Tablet: Coated., Oxybutynin - Concentration: 5 Mg; Pharmaceutical Form: Tablet, Paroxetine (Hydrochloride) - Concentration: 25Mg; Coated Tablet: Prolonged Release., Periciazine - Concentration: 4%; Solution: Oral; Bottle: 20Ml., Periciazine - Concentration: 10 Mg/Ml (1%); Solution: Oral; Bottle: Minimum 20 Ml., Pregabalin - Concentration: 75Mg; Pharmaceutical Form: Hard Capsule Or Tablet., Propathylnitrate - Concentration: 10Mg; Pharmaceutical Form: Tablet, Risperidone - Concentration: 1Mg/Ml; Solution: Oral; Bottle: 30Ml., Rivaroxaban - Concentration: 20Mg; Tablet: Coated., Rosuvastatin Calcium - Concentration: 20Mg; Tablet: Coated., Rosuvastatin Calcium - Concentration: 40Mg; Tablet: Coated., Rosuvastatin Calcium - Concentration: 10Mg; Tablet: Coated., Sacubitril + Valsartan - Concentration: 49Mg+51Mg; Tablet: Coated., Sitagliptin (Phosphate) - Concentration: 100Mg; Tablet: Coated., Solifenacin (Succinate) - Concentration: 10Mg; Tablet: Coated., Ticagrelor - Concentration: 90Mg; Tablet: Coated., Trazodone - Concentration: 300Mg; Coated Tablet: Prolonged Release., Trimetazidine (Dihydrochloride) - Concentration:
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
78a5bb41-20c4-49c7-a5b3-1a07ffd67712.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.